Fulton Breakefield Broenniman’s TSMC TSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$54.3M Sell
160,797
-48,074
-23% -$16.5M 3.54% 8
2025
Q4
$63.5M Sell
208,871
-4,232
-2% -$1.24M 4.01% 7
2025
Q3
$59.5M Sell
213,103
-5,483
-3% -$1.34M 3.84% 6
2025
Q2
$49.5M Sell
218,586
-4,465
-2% -$827K 3.35% 5
2025
Q1
$37M Sell
223,051
-564
-0.3% -$110K 2.67% 9
2024
Q4
$44.2M Sell
223,615
-4,086
-2% -$791K 3.15% 6
2024
Q3
$39.5M Sell
227,701
-3,608
-2% -$615K 2.76% 7
2024
Q2
$40.2M Buy
231,309
+297
+0.1% +$45.1K 2.97% 6
2024
Q1
$31.4M Buy
231,012
+42,179
+22% +$5.24M 2.42% 13
2023
Q4
$19.6M Buy
188,833
+2,136
+1% +$204K 1.58% 23
2023
Q3
$16.2M Buy
186,697
+1,177
+0.6% +$111K 1.41% 25
2023
Q2
$18.7M Buy
185,520
+46,297
+33% +$4.31M 1.55% 22
2023
Q1
$13M Buy
139,223
+3,540
+3% +$318K 1.11% 39
2022
Q4
$10.1M Buy
135,683
+4,184
+3% +$303K 0.9% 45
2022
Q3
$9.02M Buy
+131,499
New +$10.9M 0.85% 47

Other funds holding TSM

Fulton Breakefield Broenniman's TSM Position: Q1 2026 in Review

Fulton Breakefield Broenniman reduced its TSMC (TSM) stake by 23% in Q1 2026, selling an estimated $16.5M and leaving 160,797 shares worth $54.3M. The position accounts for 3.54% of the portfolio, ranked #8.

Fulton Breakefield Broenniman first reported a position in TSM in Q3 2022 and has held it in 15 quarters since. The position peaked at $63.5M in Q4 2025. 3,255 funds tracked by Wall St. Rank hold TSM as of Q1 2026.

  • Fulton Breakefield Broenniman held 160,797 shares of TSMC worth $54.3M as of Q1 2026.
  • Fulton Breakefield Broenniman sold 48,074 TSMC shares in Q1 2026, an estimated $16.5M.
  • TSMC made up 3.54% of Fulton Breakefield Broenniman's portfolio in Q1 2026, its #8 holding.
  • Fulton Breakefield Broenniman first reported a position in TSMC in Q3 2022 and has held it in 15 quarters since.
  • Fulton Breakefield Broenniman's TSMC position peaked at $63.5M in Q4 2025.
  • 3,255 funds tracked by Wall St. Rank held TSMC as of Q1 2026.

Based on Fulton Breakefield Broenniman's 13F filing for Q1 2026, filed 27 Apr 2026.